| Pharmaceutical Information |
| Drug Name |
Estramustine phosphate |
| Drug ID |
BADD_D00827 |
| Description |
A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. |
| Indications and Usage |
Not Available |
| Marketing Status |
approved; investigational |
| ATC Code |
L01XX11 |
| DrugBank ID |
DB14674
|
| KEGG ID |
D02398; D06397; D04066
|
| MeSH ID |
D004961
|
| PubChem ID |
259329
|
| TTD Drug ID |
D03SRY
|
| NDC Product Code |
Not Available |
| UNII |
MUZ9585Y7B
|
| Synonyms |
Estramustine | Estracyt | Estramustine Phosphate Sodium | Phosphate Sodium, Estramustine | Leo-275 | Leo 275 | Leo275 | NSC-89199 | NSC 89199 | NSC89199 | Emcyt | Estramustinphosphate | Estramustin Phosphate | Phosphate, Estramustin |
|
| Chemical Information |
| Molecular Formula |
C23H32Cl2NO6P |
| CAS Registry Number |
4891-15-0 |
| SMILES |
CC12CCC3C(C1CCC2OP(=O)(O)O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
